TMCnet News

Novanta to Present at the CJS Securities 18th Annual "New Ideas" Summer Conference on Tuesday, July 10, 2018
[June 19, 2018]

Novanta to Present at the CJS Securities 18th Annual "New Ideas" Summer Conference on Tuesday, July 10, 2018


BEDFORD, Mass., June 19, 2018 /CNW/ -- Novanta Inc. (Nasdaq: NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, and Janie Goddard, President of Novanta's JADAK business unit, are scheduled to present at the CJS Securities 18th Annual "New Ideas" Summer Conference on Tuesday, July 10, 2018, in White Plains, NY.

A copy of the presentation will be available on the Investor Relations section of the Company's website at www.novanta.com.

About Novanta

Novanta is a leading global supplier of core technology solutions that give medical and advanced industrial original equipment manufacturers ("OEMs") a competitive advantage. We combine deep proprietary technology expertiseand competencies in photonics, vision and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta's common shares are quoted on Nasdaq under the ticker symbol "NOVT".



More information about Novanta is available on the Company's website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or [email protected].

Novanta Inc.
Investor Relations Contact:
Robert J. Buckley
(781) 266-5137


Novanta logo

 

Cision View original content with multimedia:http://www.prnewswire.com/news-releases/novanta-to-present-at-the-cjs-securities-18th-annual-new-ideas-summer-conference-on-tuesday-july-10-2018-300668540.html

SOURCE Novanta Inc.


[ Back To TMCnet.com's Homepage ]